CLINICAL_TRIALS
research
· 2026-03-16
Clinical Trial Update: Allopregnanolone in Chronic Complex Traumatic Brain Injury [Phase 2]
Summary
A Phase 2 clinical trial evaluating allopregnanolone for chronic complex traumatic brain injury is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Office of Research and Development | Conditions: Traumatic Brain Injury (TBI) | Phase 2 | Status: NOT_YET_RECRUITING